|
|
 |
|
Viewing report
|
|
|
|
Business Opportunities in China: The Impact of the WTO – 2nd Edition
Pharmalicensing Ltd., March 2006, Pages: 28
This report discusses the state of the Chinese pharmaceutical industry and the opportunities available to companies doing business in China, and is aimed at individuals in business development and technology transfer looking to expand into China. China is one of the largest pharmaceuticals-producing countries in the world, and as it joins the World Trade Organization (WTO), it will need to integrate more completely into the global economy. This international competition will place an intense pressure on the Chinese pharmaceutical industry, and further open the door to a lucrative market for non-Chinese companies, especially for pharmaceutical producers and manufacturers.
This second edition, updated with new figures and tables based on Chinese official statistics, provides an overview of the development of the Chinese pharmaceutical industry and its current status, and a discussion of the competitiveness of the Chinese pharmaceutical industry in the international market. The report also provides an analysis of the business opportunities for pharmaceutical firms considering alliances in China, based on this research and the commitments made by Chinese authorities at the time of accession to the WTO, and concludes by highlighting the significant points for consideration for companies looking to capture such business opportunities in China.
The appendices include two case studies that explore examples of a 'Sino-foreign equity joint venture' and a 'Wholly foreign-owned company' in China, references, a glossary of terms, the source data used in the figures, and a resources section.
Key points covered in this report:
- The development of the Chinese pharmaceutical industry and its current status
- Changes in the industry on China's accession to the WTO
- The competitiveness of the Chinese pharmaceutical industry in the international market
- The R&D and business opportunities for pharmaceutical firms considering alliances in China
- Significant points for consideration for companies looking to capture business opportunities in China.
Who should buy this report
This report is suitable to individuals responsible for and interested in:
- Board and executive management
- Business development
- Licensing/partnering
- Deal making
- Business strategy
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Chinese Pharmaceutical Industry
Pharmaceutical Industry in China
China’s Attraction and Strategies to Work with It: Analysis of Best Strategies for Western Pharmaceutical and Biotech Companies to Partner with Chinese Pharmaceutical Companies
In-Depth Analysis of the China Pharmaceutical Market
Chinese Pharmaceutical Industry: Strategies, Trends and Opportunities
China Pharmaceutical Industry: Analysis and Market Trends
China Pharmaceutical Chain Industry Report, 2007-2008
China Pharmaceutical Chain Industry Report, 2007-2008
Latest Chinese Regulations for Imported Drug Registration: A Comprehensive Guidebook for Foreign Pharmaceutical Companies China Pharmaceutical Guidebook Series (1) (3rd edition)
China's Guidebook for Pharmaceutical Patent Protection
China Chemical Pharmaceutical Industry Report, 2007
China Chemical Pharmaceutical Industry Report, 2007
|
|
|
|
